![]() | ![]() |
Formats:
|
||||||||||||||||||||
Propagation of the [PIN+] prion by fragments of Rnq1 fused to GFP Department of Biological Sciences, University of Illinois at Chicago, 900 S. Ashland M/C567, Chicago, IL 60607, USA Corresponding author: Susan W.Liebman, Phone: (312) 996-4662, Fax: (312) 413-2691, Email: suel/at/uic.edu The publisher's final edited version of this article is available at Curr Genet. See other articles in PMC that cite the published article.Abstract Prions are viewed as enigmatic infectious entities whose genetic properties are enciphered solely in an array of self-propagating protein aggregate conformations. Rnq1, a yeast protein with yet unknown function, forms a prion named [PIN+] for its ability to facilitate the de novo induction of another prion, [PSI+]. Here we investigate a set of RNQ1 truncations that were designed to cover major Rnq1 sequence elements similar to those important for the propagation of other yeast prions: a region rich in asparagines and glutamines and several types of oligopeptide repeats. Proteins encoded by these RNQ1 truncations were tested for their ability to (i) join (decorate) pre-existing [PIN+] aggregates made of wild-type Rnq1 and (ii) maintain the heritable aggregated state in the absence of wild-type RNQ1. While the possible involvement of particular sequence elements in the propagation of [PIN+] is discussed, the major result is that the efficiency of transmission of [PIN+] from wild-type Rnq1 to a fragment, decreased with the fragment’s length. Keywords: Rnq1 [PIN+] yeast prion [PSI+] induction Introduction Many proteins can take on an alternative β-sheet-rich conformation in which they polymerize into amyloid aggregates (Chiti and Dobson 2006). Sometimes, this state is infectious and, in such cases, is referred to as a prion (Prusiner 2004). The infectivity is based upon a prion’s ability to convert soluble molecules of the same protein into the amyloid form, and the ability of these amyloid aggregates to break and segregate, resulting in multiple seeds for further conversion (Serpell et al. 1997;Borchsenius et al. 2001). Therefore, prions can be regarded as genetic elements although they are solely proteinaceous (Wickner et al. 2004). The first characterized prion, mammalian PrPSc is a pathogenic agent causing a series of neurodegenerative disorders, e.g. Creutzfeldt-Jackob disease, Gerstmann-Strasussler syndrome, fatal familial insomnia, and kuru in humans; scrapie in sheep; spongiform encephalopathy in cows (Prusiner 1998). The recent discovery of prion-like factors in other organisms: [PSI+], [URE3], and [PIN+] in Saccharomyces cerevisiae and [Het-s] in Podospora anserina (Wickner 1994; Coustou et al. 1997; Derkatch et al. 2001) facilitated the search for general criteria of prionogenicity in a protein’s primary structure. This problem has been approached in many studies (DePace et al. 1998; Parham et al. 2001; Bradley and Liebman 2004; Osherovich et al. 2004; Ross et al. 2005b) of the [PSI+] determinant (Cox et al. 1988) which is a prion form of the translational termination factor Sup35 (eRF3) (Ter-Avanesyan et al. 1994; Zhouravleva et al. 1995; Paushkin et al. 1996). Intriguingly, the de novo appearance of [PSI+] (upon overproduction of Sup35) is dependent upon the presence of another prion, [PIN+] (Derkatch et al. 1997) which is formed by Rnq1, a protein with no known function (Derkatch et al. 2001). [PIN+] also facilitates the de novo appearance of [URE3] (Derkatch et al. 2001; Bradley et al. 2002), a prion form of Ure2 (Wickner 1994) which is a regulator of nitrogen metabolism (Courchesne and Magasanik 1988). In vitro studies using recombinant proteins have shown that Rnq1 aggregates constituting [PIN+] can promote the assembly of Sup35 into [PSI+] aggregates (Derkatch et al. 2004; Vitrenko et al. 2006). Because prions arise from the misfolding of a prionogenic protein, the establishment and maintenance of prions is dependent on chaperone activity (Chernoff 2001). Propagation of [PIN+] requires Hsp104 (Derkatch et al. 2001) as well as some members of the Hsp40 and Hsp70 chaperone families (Bradley et al. 2002; Lopez et al. 2003; Aron et al. 2005). The dependence on Hsp104 is assumed to result from Hsp104’s primary function of fragmentation, with partitioning being a consequence of this activity. This Hsp104 activity has been shown to be crucial for the propagation of [PSI+] (Chernoff et al. 1995; Borchsenius et al. 2001; Jung et al. 2002; Kryndushkin et al. 2003) and [URE3] (Moriyama et al. 2000). Likewise, there seems to be a reverse correlation between Hsp104 activity and the size of detergent-resistant aggregates of [PSI+] (Kryndushkin et al. 2003) and [PIN+] (Bagriantsev and Liebman 2004). Prions can exist in multiple forms producing distinct phenotypes (Derkatch et al. 1996; Prusiner 1998; Schlumpberger et al. 2001). These prion “strains” or “variants” arise from the ability of a single prionogenic protein to polymerize into structurally different aggregates (Tanaka et al. 2004; Krishnan and Lindquist 2005; Spassov et al. 2006). Similarly, [PIN+] variants have been characterized that exhibit different levels of [PSI+] induction. The variants were hence named “very high” (the most efficient [PSI+] inducer), “high”, “medium” and “low” [PIN+] (very inefficient [PSI+] inducer). Rnq1 forms aggregates in all of these strains (Bradley et al. 2002). Regions sufficient for prionization (‘prion domains’) have been delineated for [PSI+] (Ter-Avanesyan et al. 1994), [URE3] (Masison and Wickner 1995; Maddelein and Wickner 1999; Schlumpberger et al. 2000) and [PIN+]/[RNQ+] (Sondheimer and Lindquist 2000). The primary structures of these domains display some similarities, e.g. all are rich in asparagines and glutamines (QN-rich). More than 170 QN-rich prion-like sequences were found in an analysis of the yeast genome (Harrison and Gerstein 2003). Yet no universal criteria for the prediction of prionogenic properties have been established. Interestingly, the P. anserina prion [Het-s] has no QN-rich domain but can be efficiently propagated as a prion in yeast (Taneja 2006). Likewise, PrP is not QN-rich (Oesch et al. 1985), however, the PrP sequence, like Sup35 and Rnq1, does contain imperfect oligopeptide repeats. Furthermore, altering the number of repeats in Sup35 (Liu and Lindquist 1999; Parham et al. 2001) and PrP (Rogers et al. 1993) affects the probability of conversion into the prion form. Intriguingly, randomization (scrambling) of sequences of Sup35 and Ure2 prion domains, while keeping the amino acid composition the same as in the wild-type versions, did not result in the loss of prion-forming abilities of the corresponding proteins (Ross et al. 2004; Ross et al. 2005a). We made and characterized different fragments of Rnq1 and examined them for the ability to propagate two [PIN+] variants. Two phenotypes characteristic of [PIN+] were specifically scored for these fragments: the formation of Rnq1 aggregates and ability to facilitate the induction of [PSI+]. Differences in the efficiency with which Rnq1 fragments can be converted to a stable prion by wild-type Rnq1 aggregates appear to be linked to the fragment length. Materials and Methods Yeast strains and cultivation procedures All MATa strains used are derivatives of 74-D694 (MATa ade1-14 trp1-289 his3-Δ200 leu2-3,112 ura3-52) (Chernoff et al. 1993): L1751 is [pin−] (Derkatch et al. 1997), L1749 is high [PIN+] (Derkatch et al. 1997), L1943 is low [PIN+] (Bradley et al. 2002). L2668 is MATα ade1-14 ura3-52 leu2-3,112 trp1-289 his3-200 kar1-Δ15 can1R cyh2R rnq1 KanMX4 (Bradley and Liebman 2003). Standard cultivation procedures were followed. Yeast was incubated at 30°C unless otherwise indicated. Synthetic media containing dextrose (SD) lacking one or two amino acids were used to select for the corresponding nutritional markers, e.g. media lacking histidine or uracil are denoted, respectively, SD-His or SD-Ura. Synthetic medium containing galactose and raffinose (SGal +raffinose) instead of dextrose was used for the inducible overexpression of SUP35 from the GAL1 promoter. Copper sulfate (50 µM) was added to media to drive the expression of rnq1 alleles from the CUP1 promoter.Plasmids The rnq1-Δ1…Δ7, -ΔN1 alleles were generated with PCR using the primers listed in Table 1. The template, pYV10 RNQ1:GFP, was made from pID116, a centromeric HIS3-marked vector, containing RNQ1 fused to GFP under the control of the CUP1 promoter (Derkatch unpublished) in which we replaced the CUP1 promoter with the RNQ1 native promoter on an XhoI – BamHI fragment. Since attempts to transfer [PIN+] to the rnq-Δ strain L2668 expressing plasmid-born wild-type RNQ1 from the native promoter failed (data not shown) we constructed plasmids in which the rnq1 alleles were more highly expressed from the CUP1 promoter. The PCR-generated fragments were cloned into pID116 as BamHI – SacII inserts in place of the BamHI – SacII fragment carrying RNQ1, to yield the pCUP-rnq1-x:GFP constructs used in this study (x stands for one of the rnq1 alleles). pID116 was used as an RNQ1 positive control and also to make the ‘empty vector’ pCUP:GFP and ‘QN-rich region only’ construct pCUP:rnq1-ΔN2:GFP by cutting out the BamHI – SacII and BamHI – Van91I fragments, respectively. For [PSI+] induction, we used pGAL:SUP35, a centromeric, URA3-marked plasmid (Derkatch et al. 1996). pRS415 (Sikorski and Hieter 1989) was used to provide the LEU2 selectable marker when needed.
GFP-based assay of Rnq1 aggregation (decoration assay) L1751, L1749 and L1943 bearing pGAL:SUP35 (URA3) were crossed with L2668 bearing pCUP-rnq1-x:GFP (HIS3), and progeny was selected on SD-His-Ura +50 µM CuSO4. Mating type verification showed that most of this progeny are diploids. Colonies were picked to 1 µl water, and examined on glass slides using a Zeiss Axioskop 2 equipped with x40 Plan-Neofluar objective lens. Only cells emitting green fluorescence were scored and their total number was used as the total in all percentages presented. [PIN+] transfer via cytoduction [PIN+] was transferred from a wild-type RNQ1 strain to rnq1-Δ pCUP-rnq1-x:GFP strains by cytoduction. This technique results in mixing the cytoplasms of two strains crossed while retaining the nucleus from only one strain called, therefore, the recipient. Nuclear fusion is prevented by the kar1-1 allele present in one of the strains (Conde and Fink 1976). The recipient nucleus has cyh2R, a recessive cycloheximide resistance allele facilitating selection (on cycloheximide-containing medium) of progeny retaining only the recipient nucleus. While cytoduction is generally performed by selecting for the transfer of mitochondria from a donor to a recipient, better [PIN+] transfer was achieved when we selected for the fusion of donor and recipient cytoplasms using the plasmid-born URA3 and HIS3 markers, respectively. This technique called plasmiduction has been described previously (Natsoulis et al. 1994). For transfer of cytoplasm from [pin−] (L1751), high (L1749) and low [PIN+] (L1943) donors (transformed with pGAL:SUP35) to the [pin−] recipient L2668 (transformed with pCUP-rnq1-x:GFP), donor and recipient strains were mated on YPD + 50 µM CuSO4 overnight, and the mating patches were then replica plated onto SD-Ura-His + 50 µM CuSO4 + 3 µg / ml cycloheximide. From this medium, Ura+ His+ CyhR colonies were picked, their mating type and markers were verified to make sure they were cytoductants. Assaying cytoductants for [PIN+] Rnq1–x:GFP aggregation was scored directly in cytoductants by microscopic examination of GFP fluorescence as described above. To assay the cytoductants’ ability to induce [PSI+], plates of cytoductants were replicated to YPD + 50 µM CuSO4 (to obtain thick uniform patches) and then either onto SGal – His – Ura + 50 µM CuSO4 + 2% raffinose (SUP35 inducing medium) or SD – His – Ura + 50 µM CuSO4 (non-inducing medium). After two passages on these media, cytoductants were replica plated onto SD-Ade and incubated for two weeks at +20°C. We scored cytoductants as being able to induce [PSI+] only if Ade+ papillation was higher following growth on inducing vs non-inducing medium. We verified in pilot experiments (data not shown) that induced Ade+ colonies are usually GuHCl-curable. Thus, as shown previously (Chernoff et al. 1993; Derkatch et al. 1997), induced Ade+ papillation can be used to score for [PSI+] appearance and hence the inheritance of [PIN+] by cytoductants. Western blot analysis To analyze the expression and aggregation levels of the Rnq1 fragments, lysates were made from 100 ml SD-His + 50 µM CuSO4 saturated cultures. Harvested cells were resuspended in 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 5 mM MgCl 0.1% Triton X-100 5 mM PMSF, 1:50 protease inhibitor cocktail (Sigma; cat. # 8215) (Bagriantsev and Liebman 2004) and vigorously shaken with an equal volume of 0.5-mm glass beads (BioSpec Products) in a vortex equipped with a tube holder for 10–60 min at +4°C. An additional dose of 5 mM PMSF was added after half of the incubation time. Lysates were precleared by centrifugation at 600 × g for 1 min and normalized for the total protein concentration using Bradford Protein Assay Reagent (Biorad). Lysates were analyzed either on SDS-polyacrylamide (after boiling for 7 min) or SDS-agarose gels (without boiling) and were then transferred to a PVDF membrane. Biorad components and recommendations were used with modifications for SDS-agarose gels described earlier (Bagriantsev and Liebman 2004). Membranes were probed with 1:5000 anti-GFP antibody (Sigma; cat. # G1544) using a Western-Star™ immunodetection kit (Applied Biosystems). Hydrophobicity profiles The Rnq1 sequence (Saccharomyces Genome Database #YCL028W) was analyzed by the Kyte-Doolittle algorithm (Kyte and Doolittle 1982) using the ProtScale program (http://ca.expasy.org/tools/protscale.html) with the window set at 9 aa. Analysis of hydrophobicity by other algorithms available in ProtScale gave similar profiles. Results Analysis of Rnq1 sequence motifs The Rnq1 sequence can be divided into two halves: the N-terminal non-QN-rich (aa 1-152) and the C-terminal QN-rich (aa 153-405). The latter has been shown to be sufficient for prion formation (Sondheimer and Lindquist 2000). Several types of sequence regularities can be outlined in the QN-rich portion whose location, sequence and hydrophobicity are shown in Fig. 1a, b, and c
Design of RNQ1 alleles To investigate the role of Rnq1 sequence motifs in the propagation of [PIN+] we designed seven C-terminal truncations such that each of them removes an additional motif (rnq1-Δ1…Δ7; Fig. 1a Analysis of the ability of Rnq1 fragments to join pre-existing aggregates of wild-type Rnq1 The joining of a GFP-tagged prionogenic fragment to prion aggregates made of the homologous wild-type protein is visualized by the formation of fluorescent foci in vivo (Patino et al. 1996). To analyze Rnq1 fragments by this assay, plasmids carrying rnq1-x:GFP alleles were transformed into a strain having a complete deletion of RNQ1 (L2668) and crossed to either [pin−] (L1751), high (L1749) or low (L1943) [PIN+] strains. Thus, the Rnq1-x:GFPs encoded by these plasmids were given a chance to “decorate” the wild-type Rnq1 aggregates present in these strains (Fig. 2
In the prion state, Rnq1 forms SDS-resistant particles indicative of their amyloid structure (Bagriantsev and Liebman 2004). To see whether Rnq1-x:GFPs take on an SDS-stable conformation upon contact with wild-type Rnq1 aggregates, we analyzed them using semi-denaturing agarose gel electrophoresis and immunoblotting. SDS-resistant Rnq1-x:GFP sub-particles with molecular weights much higher than 250 kD were found in crossing rnq1- Δ4…Δ7, -ΔN1, -ΔN2, and RNQ1 :GFP transformants to high and low [PIN+] (Fig. 3
Propagation of [PIN+] by RNQ1 alleles on their own The abilitiy to join pre-existing prion aggregates does not necessarily mean that an Rnq1 fragment can propagate the inherited prion state on its own. To distinguish which of the Rnq1-x:GFP fragments indeed propagates the prion state, [PIN+] was transferred to an rnq1-Δ strain harboring our rnq1-x:GFP constructs (Fig. 4
These cytoductants were assayed for two [PIN+]-related phenotypes: the formation of Rnq1:GFP aggregates and the ability to facilitate [PSI+] induction following overexpression of SUP35. In addition, the cytoductants with fluorescent foci had SDS-resistant subparticles Rnq1-x (Fig. S1) similar to those shown in Fig. 3
Surprisingly, [PIN+] was only transferred with low efficiency to the N-terminal truncation Rnq1-ΔN2:GFP (aa 133-405) which contained the entire presumptive prion domain. In contrast, transfer of [PIN+] to the N-terminal truncation Rnq1-ΔN1:GFP (aa 172-405), that lacked motif A suggested to be important for aggregation in an earlier polymorphism study, was quite efficient (Resende et al. 2003). Interestingly, Rnq1-ΔN1:GFP did not respond differently to the two [PIN+] variants and produced aggregates even in some cytoductants from a [pin−] donor (compared to the almost zero background of aggregation in [pin−] cytoductants for all other alleles). This suggests Rnq1-ΔN1’s higher propensity to form [PIN+] spontaneously. The [PSI+] induction assay is another way to score for [PIN+] in addition to GFP fluorescence. To facilitate controllable SUP35 overexpression required for this assay, each cytoductant inherited a galactose-inducible SUP35 construct used in earlier [PIN+] studies (Derkatch et al. 1997). Because [PSI+] results in loss-of-function of the translational termination factor Sup35 and consequent nonsense suppression (Ter-Avanesyan et al. 1994), the appearance of [PSI+] is scored by the rescue of adenine prototrophy in cytoductants bearing the nonsense mutation ade1-14 (Cox et al. 1988). While many cytoductants derived from the high [PIN+] donor displayed induced Ade+ papillation of the same density as the donor high [PIN+] strain (Fig. 5
As expected, generally both or neither phenotype was present in a given cytoductant indicating the presence or absence of high [PIN+], respectively. The arbitrarily set 10% boundary for scoring cytoductants as containing GFP foci and the qualitative nature of the [PSI+] induction assay could be the cause of some of these exceptions. Discussion Sequence analysis The goal of the molecular dissection of Rnq1 was to determine what primary structural elements are required for the acquisition of the prion state. We looked at the Rnq1 amino acid sequence in the light of the importance of oligopeptide repeats postulated for other prions (Prusiner et al. 1993; Liu and Lindquist 1999; Parham et al. 2001). While only one type of imperfect oligopeptide repeat is found in Sup35 (Kushnirov et al. 1988) and PrP (Oesch et al. 1985), Rnq1 contains different types of repeats (Fig.1b Limitations of the deletion analysis Of course, differences in prion conversion could be observed between two neighboring deletions not because of one extra oligopeptide repeat’s presence but simply because of the difference in the protein’s length. Indeed, Ross et al (2005) demonstrated that a high QN content, not any particular sequence was the main requirement for Sup35 and Ure2 prionogenicity. Therefore, the amount of QN retained in Rnq1 fragments may explain their ability to maintain [PIN+]. While, in general we can not rule out this explanation, it does not seem to be applicable for all of the Rnq1 fragments. For example, Rnq-Δ4 and -Δ3 are distinguished from each other by a 29-aa segment having only 6 Q’s and 1 N; Rnq-Δ5 and -Δ6 are distinguished by a 19-bp segment having no Q’s and only 3 N’s. Thus the distinguishing sequence for these pairs of neighboring deletions is not QN rich yet they differ in the efficiency of [PIN+] inheritance (Table 2 and Table 3). In these two examples, the frequency of Q and N in the extensions is as low as in the non-QN-rich domain. It, therefore, appears that some other features of the amino acid composition contribute to the higher prionogenicity of longer Rnq1 fragments in addition to the QN content. These could be the oligopeptide repeats and the non-random alteration of polar and hydrophobic stretches throughout Rnq1. Motifs covered by C-terminal deletions The first striking result of our analysis is that a shorter region is sufficient for joining pre-existing aggregates (Table 2 and Fig. 3 We did not see any difference in the efficiency of decoration of pre-existing aggregates between low and high [PIN+] for all Rnq1 fragments (Table 2) while the efficiency of transfer of these two variants was dramatically different (Table 3). The transfer efficiency could be encrypted in the variant-specific conformation of prion aggregates per se as has been previously proposed for [PSI+] (Tanaka et al. 2004; Krishnan and Lindquist 2005). The addition of a short sequence containing a spaced tandem repeat (motif G; compare Rnq1-Δ6 and -Δ7) appears to increase the infectivity of both high and low [PIN+] (Table 3). The sequence of motif G suggests its ability to form a mini β sheet and further stabilize the amyloid structure via “polar zipper”-like interactions (Perutz et al. 1993). In the light of hypotheses proposed in a structural study of a short Sup35 peptide (Nelson et al. 2005), this exemplifies the necessity of a balance between hydrophobic and polar interactions for the formation of properly folded and replicated prion aggregates. N-terminal deletions The results obtained for the two N-terminal deletions Rnq1-ΔN2 and Rnq1-ΔN1 were surprising. Rnq1-ΔN1:GFP, the shorter fragment, formed [PIN+] quite efficiently (Table 3). Because Rnq-ΔN1:GFP produced [PIN+] in some cytoductants that received [pin−] cytoplasm, we suggest that Rnq1-ΔN1:GFP frequently folds de novo into [PIN+] aggregates. It seemed contradictory that Rnq1-ΔN2:GFP, which is longer, did not increase the spontaneous appearance of [PIN+]. One possibility is that this is due to a lower level of the Rnq1-ΔN2:GFP protein (Fig. 1d Significance for structural studies A major direction of prion studies is the determination of the prion structure. While significant progress has been made for [PSI+] (Balbirnie et al. 2001; Krishnan and Lindquist 2005; Nelson et al. 2005);(Shewmaker et al. 2006) and [URE3] (Bousset et al. 2002) (Baxa et al. 2003) (Fay et al. 2005), such studies will be more difficult for [PIN+] partially because aggregates of wild-type Rnq1 and its C-terminal domain are globular (Vitrenko et al. 2006) unlike those of the other prions which have fiber-like aggregates (Glover et al. 1997; Taylor et al. 1999). This makes Rnq1 less amenable to structural studies always benefiting from a more ordered composition of the substrate. In view of this, one of the shorter Rnq1 fragments presented here could be a better model for the structural analyses in vitro, as it is expected to aggregate into higher ordered species. Indeed, most information on prion structure has been collected from shorter fragments of prion domains (Balbirnie et al. 2001; Laws et al. 2001; Nelson et al. 2005). The molecular dissection of Rnq1 and in vivo characterization of the resulting fragments is an important step towards understanding prion phenomena both from basic and applied perspectives. 01 Fig. S1 Cytoductants with no wild-type Rnq1 that were scored as [PIN+] have SDS-resistant subparticles of Rnq1:x-GFP. Lysates of representative cytoductants scored as [pin−] or high [PIN+] as labeled were subjected to SDS-AGE and immunoblotted with anti-GFP antibody. Lysates were made from cultures containing GFP aggregates in more than 50° of the cells. The Rnq1-x:GFP fragments expressed in the cytoductants are as labeled. Click here to view.(145K, pdf) Acknowledgments We thank Irina Derkatch for the pID116 plasmid. This work was supported by a grant from the National Institutes of Health (GM56350 to S.W.L). References
|
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Annu Rev Biochem. 2006; 75():333-66.
[Annu Rev Biochem. 2006]Cell Mol Life Sci. 1997 Dec; 53(11-12):871-87.
[Cell Mol Life Sci. 1997]EMBO J. 2001 Dec 3; 20(23):6683-91.
[EMBO J. 2001]Genes Dev. 2004 Mar 1; 18(5):470-85.
[Genes Dev. 2004]Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13363-83.
[Proc Natl Acad Sci U S A. 1998]Cell. 1998 Jun 26; 93(7):1241-52.
[Cell. 1998]EMBO J. 2001 May 1; 20(9):2111-9.
[EMBO J. 2001]Mol Microbiol. 2004 Mar; 51(6):1649-59.
[Mol Microbiol. 2004]PLoS Biol. 2004 Apr; 2(4):E86.
[PLoS Biol. 2004]Nat Cell Biol. 2005 Nov; 7(11):1039-44.
[Nat Cell Biol. 2005]Mutat Res. 2001 Mar; 488(1):39-64.
[Mutat Res. 2001]Cell. 2001 Jul 27; 106(2):171-82.
[Cell. 2001]Proc Natl Acad Sci U S A. 2002 Dec 10; 99 Suppl 4():16392-9.
[Proc Natl Acad Sci U S A. 2002]Mol Biol Cell. 2003 Mar; 14(3):1172-81.
[Mol Biol Cell. 2003]Genetics. 2005 Apr; 169(4):1873-82.
[Genetics. 2005]Genetics. 1996 Dec; 144(4):1375-86.
[Genetics. 1996]Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13363-83.
[Proc Natl Acad Sci U S A. 1998]Mol Cell Biol. 2001 Oct; 21(20):7035-46.
[Mol Cell Biol. 2001]Nature. 2004 Mar 18; 428(6980):323-8.
[Nature. 2004]Nature. 2005 Jun 9; 435(7043):765-72.
[Nature. 2005]Genetics. 1994 Jul; 137(3):671-6.
[Genetics. 1994]Science. 1995 Oct 6; 270(5233):93-5.
[Science. 1995]Mol Cell Biol. 1999 Jun; 19(6):4516-24.
[Mol Cell Biol. 1999]Protein Sci. 2000 Mar; 9(3):440-51.
[Protein Sci. 2000]Mol Cell. 2000 Jan; 5(1):163-72.
[Mol Cell. 2000]Curr Genet. 1993 Sep; 24(3):268-70.
[Curr Genet. 1993]Genetics. 1997 Oct; 147(2):507-19.
[Genetics. 1997]Proc Natl Acad Sci U S A. 2002 Dec 10; 99 Suppl 4():16392-9.
[Proc Natl Acad Sci U S A. 2002]Genetics. 2003 Dec; 165(4):1675-85.
[Genetics. 2003]Genetics. 1996 Dec; 144(4):1375-86.
[Genetics. 1996]Genetics. 1989 May; 122(1):19-27.
[Genetics. 1989]Proc Natl Acad Sci U S A. 1976 Oct; 73(10):3651-5.
[Proc Natl Acad Sci U S A. 1976]Genetics. 1994 Jan; 136(1):93-105.
[Genetics. 1994]Curr Genet. 1993 Sep; 24(3):268-70.
[Curr Genet. 1993]Genetics. 1997 Oct; 147(2):507-19.
[Genetics. 1997]J Biol Chem. 2004 Dec 3; 279(49):51042-8.
[J Biol Chem. 2004]J Mol Biol. 1982 May 5; 157(1):105-32.
[J Mol Biol. 1982]Mol Cell. 2000 Jan; 5(1):163-72.
[Mol Cell. 2000]Mol Microbiol. 2003 Aug; 49(4):1005-17.
[Mol Microbiol. 2003]Nature. 2005 Jun 9; 435(7043):773-8.
[Nature. 2005]Mol Cell. 2000 Jan; 5(1):163-72.
[Mol Cell. 2000]Science. 1996 Aug 2; 273(5275):622-6.
[Science. 1996]Mol Cell. 2000 Jan; 5(1):163-72.
[Mol Cell. 2000]J Biol Chem. 2004 Dec 3; 279(49):51042-8.
[J Biol Chem. 2004]Mol Microbiol. 2003 Aug; 49(4):1005-17.
[Mol Microbiol. 2003]Genetics. 1997 Oct; 147(2):507-19.
[Genetics. 1997]Genetics. 1994 Jul; 137(3):671-6.
[Genetics. 1994]Yeast. 1988 Sep; 4(3):159-78.
[Yeast. 1988]J Infect Dis. 1993 Mar; 167(3):602-13.
[J Infect Dis. 1993]Nature. 1999 Aug 5; 400(6744):573-6.
[Nature. 1999]EMBO J. 2001 May 1; 20(9):2111-9.
[EMBO J. 2001]Gene. 1988 Jun 15; 66(1):45-54.
[Gene. 1988]Cell. 1985 Apr; 40(4):735-46.
[Cell. 1985]EMBO Rep. 2003 Jun; 4(6):565-70.
[EMBO Rep. 2003]Cell. 2001 Jul 27; 106(2):171-82.
[Cell. 2001]Mol Cell Biol. 2003 Nov; 23(21):7554-65.
[Mol Cell Biol. 2003]PLoS Biol. 2004 Apr; 2(4):E86.
[PLoS Biol. 2004]Nature. 2004 Mar 18; 428(6980):323-8.
[Nature. 2004]Nature. 2005 Jun 9; 435(7043):765-72.
[Nature. 2005]Curr Biol. 1993 May 1; 3(5):249-53.
[Curr Biol. 1993]Nature. 2005 Jun 9; 435(7043):773-8.
[Nature. 2005]Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2375-80.
[Proc Natl Acad Sci U S A. 2001]Nature. 2005 Jun 9; 435(7043):765-72.
[Nature. 2005]Nature. 2005 Jun 9; 435(7043):773-8.
[Nature. 2005]Proc Natl Acad Sci U S A. 2006 Dec 26; 103(52):19754-9.
[Proc Natl Acad Sci U S A. 2006]C R Biol. 2002 Jan; 325(1):3-8.
[C R Biol. 2002]